# Stefan Störk

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/stefan-stork/

## Facts

| Field | Value |
| --- | --- |
| Citations | 24,242 |
| Field | Heart Failure Treatment and Management |
| h-index | 74 |
| i10-index | 284 |
| Last Known Institution | Universitätsklinikum Würzburg |
| OpenAlex ID | https://openalex.org/A5084986659 |
| ORCID iD | 0000-0002-1771-7249 |
| Works | 654 |

## Researcher papers

- [Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease](https://scholariq.org/papers/rivaroxaban-with-or-without-aspirin-in-stable-cardiovascular-disease/)
- [EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries](https://scholariq.org/papers/euroaspire-iv-a-european-society-of-cardiology-survey-on-the-lifestyle-risk/)
- [Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry](https://scholariq.org/papers/lifestyle-and-impact-on-cardiovascular-risk-factor-control-in-coronary-patients/)
- [Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/rivaroxaban-with-or-without-aspirin-in-patients-with-stable-peripheral-or/)
- [Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial](https://scholariq.org/papers/efficacy-of-telemedical-interventional-management-in-patients-with-heart-failure/)
- [Impact of Myocardial Fibrosis in Patients With Symptomatic Severe Aortic Stenosis](https://scholariq.org/papers/impact-of-myocardial-fibrosis-in-patients-with-symptomatic-severe-aortic/)
- [Long-Term Effects of Enzyme Replacement Therapy on Fabry Cardiomyopathy](https://scholariq.org/papers/long-term-effects-of-enzyme-replacement-therapy-on-fabry-cardiomyopathy/)
- [Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin](https://scholariq.org/papers/safety-of-proton-pump-inhibitors-based-on-a-large-multi-year-randomized-trial-of/)
- [Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/heart-failure-in-chronic-kidney-disease-conclusions-from-a-kidney-disease/)
- [Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries](https://scholariq.org/papers/management-of-dyslipidaemia-in-patients-with-coronary-heart-disease-results-from/)
- [Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction](https://scholariq.org/papers/digitoxin-in-patients-with-heart-failure-and-reduced-ejection-fraction/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)
- [Cardiac Health and Mental Health](https://scholariq.org/topics/cardiac-health-and-mental-health/)
- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)

## Researcher university

- [Universitätsklinikum Würzburg](https://scholariq.org/institutions/universitatsklinikum-wurzburg/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.